Figure 6C and 6D showed that Met and Erlo alone administrated was able to partially reduce the number of Ki67+ cells and combination of Met and Erlo exhibited a greater effect to diminish the Ki67+ cells in the xenograft tumor tissues than any single agent alone seen 30 days after tumor cell implantation. Here, MKI67 is linked to neoplasm.